Bea Lydecker’s Naturals, Inc. Warning Letter Details

Summary

Bea Lydecker's Naturals, Inc. was cited for marketing multiple products—including dietary supplements and CBD Oil—with disease treatment and prevention claims that caused them to be classified as unapproved new drugs in violation of the Federal Food, Drug, and Cosmetic Act. The FDA found that 15 products including Enzymes Plus, Artho Flex, Immune, and Heart/Blood Vessel were misbranded and intended for uses such as curing, mitigating, treating, or preventing disease without FDA approval. Additionally, the company promoted products intended to treat, prevent, diagnose, or cure COVID-19 in humans and animals, and marketed CBD products for both human and animal use without appropriate regulatory authorization.